Literature DB >> 11123504

The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations.

J Apelqvist, M Eneroth.   

Abstract

OBJECTIVES: To compare the correspondence of discharges and diagnoses between medical records and an administrative database in diabetic patients with foot ulcers and to calculate inpatient costs from the different sources.
DESIGN: Discharge data from 117 prospectively followed patients were compared with information from the Swedish Inpatient Registry during the same treatment period for each patient. Non corresponding discharges were retrospectively reviewed in patient records. Costs of inpatient care were calculated from clinical sources and from data selected in three different ways from the database. Information in medical records was assumed to represent the 'Gold Standard'.
SETTING: In-hospital treatment, multidisciplinary foot-care team.
SUBJECTS: A total of 117 diabetic patients with deep foot infections. MAIN OUTCOME MEASURES: Degree of database completeness and inpatient costs.
RESULTS: The degree of completeness of discharges in the database was 98%, but 8.6% of discharges had no code for diabetes and 13% were registered without any foot related diagnosis code. Less than 20% of discharges were found with selection based on primary diagnosis 250.G only. Total inpatient costs varied from 2.7 to 13.3 million SEK (Swedish Kronor) depending on selected diagnosis codes. Approximately 84% of all foot ulcer discharges could be found in the database if codes with both diabetes mellitus and foot ulcer diagnoses were selected.
CONCLUSIONS: Inpatient costs for foot complications cannot be accurately estimated from the Inpatient Registry when based on primary diagnosis exclusively. Fairly good estimates at a low data acquisition cost can be made with a combination of foot related diagnoses together with codes for diabetes.

Entities:  

Mesh:

Year:  2000        PMID: 11123504     DOI: 10.1046/j.1365-2796.2000.00748.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  10 in total

1.  A review of the Eurodiale studies: what lessons for diabetic foot care?

Authors:  Simeen Akhtar; Nicolaas Schaper; Jan Apelqvist; Edward Jude
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

2.  Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.

Authors:  Fay Crawford; Francesca M Chappell; James Lewsey; Richard Riley; Neil Hawkins; Donald Nicolson; Robert Heggie; Marie Smith; Margaret Horne; Aparna Amanna; Angela Martin; Saket Gupta; Karen Gray; David Weller; Julie Brittenden; Graham Leese
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

3.  Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study.

Authors:  Björn Rathsman; Kerstin Jensen-Urstad; Thomas Nyström
Journal:  Diabetologia       Date:  2014-05-07       Impact factor: 10.122

Review 4.  Cost of diabetic eye, renal and foot complications: a methodological review.

Authors:  Solène Schirr-Bonnans; Nadège Costa; Hélène Derumeaux-Burel; Jérémy Bos; Benoît Lepage; Valérie Garnault; Jacques Martini; Hélène Hanaire; Marie-Christine Turnin; Laurent Molinier
Journal:  Eur J Health Econ       Date:  2016-03-14

5.  Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.

Authors:  Tomas Forslund; Björn Wettermark; Per Wändell; Mia von Euler; Jan Hasselström; Paul Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  2014-09-16       Impact factor: 2.953

6.  Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study.

Authors:  L Prompers; M Huijberts; N Schaper; J Apelqvist; K Bakker; M Edmonds; P Holstein; E Jude; A Jirkovska; D Mauricio; A Piaggesi; H Reike; M Spraul; K Van Acker; S Van Baal; F Van Merode; L Uccioli; V Urbancic; G Ragnarson Tennvall
Journal:  Diabetologia       Date:  2008-07-22       Impact factor: 10.122

7.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

8.  Risk of contralateral lower limb amputation and death after initial lower limb amputation - a population-based study.

Authors:  K Huseynova; R Sutradhar; G L Booth; A Huang; J G Ray
Journal:  Heliyon       Date:  2018-10-09

9.  Preterm birth and risk of type 1 and type 2 diabetes: a national cohort study.

Authors:  Casey Crump; Jan Sundquist; Kristina Sundquist
Journal:  Diabetologia       Date:  2019-12-05       Impact factor: 10.122

10.  Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication.

Authors:  Diana M Rydberg; Marie Linder; Rickard E Malmström; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2020-03-28       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.